Current Status
Not Enrolled
Price
Free
Get Started
Course
Materials

Program Director

Jennifer G. Robinson, MD, MPH

Program Director

Raul D Santos, MD, MSc, PhD

Preventing Atherosclerotic Cardiovascular Disease in Patients with Diabetes Mellitus

The IAS recognizes that system-level improvements are needed in the prevention of ASCVD in patients with diabetes and that progress in CVD risk factor control is slowing. Based on US data, only 14% of patients meet targets for all A1C, BP, lipids, and nonsmoking status. 33-49% of patients still do not meet one or several targets for A1C, blood pressure, or lipids. This problem is exacerbated globally as even fewer meet these targets in many low-and middle-income countries.

The purpose of this video series are to provide a better understanding of the evidence-based management of the diabetic patient to reduce ASCVD risk with focused discussion on statins and newer diabetes drugs.

Each section is introducted by general lecture of the clinical prevalence and evidence. The panel will discuss the real world implications and provide practical implemtation advice.

Pre-activity information

Not available

Futuras terapias para o tratamento da dislipidemia (Video 9 – Future Therapies for Dyslipidemia Treatment)

See more...

Not available

Uso de inibidores de PCSK9 em pacientes com hipercolesterolemia familiar (Video 8 – Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patients)

See more...

Not available

Video 5 – Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins

See more...

Not available

Video 9 – Future Therapies for Dyslipidemia Treatment – Chinese

See more...

Not available

Video 8 – Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patients – Chinese

See more...

Not available

Video 7 – Efficacy, Feasibility and Safety of Early Use of Monoclonal PCSK9 Inhibitors After an Acute Coronary Syndrome – Chinese

See more...

Not available

Video 6 – Impact of PCSK9 Inhibition in Very High-Risk Patients and How to Increase Cost Effectiveness – Chinese

See more...

Not available

Video 5 – Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins – Chinese

See more...

Not available

Video 4 – Safety of Intensive LDL-C Reduction – Chinese

See more...

Not available

Video 3 – For ASCVD Prevention the Lower the LDL-C the Better – Chinese

See more...

Not available

Video 2 – The Sad and Inadequate Reality of Cholesterol Control Worldwide – Chinese

See more...

Not available

Video 1 – Evidence of LDL-C as a Cause of Atherosclerotic Cardiovascular Disease – Chinese

See more...

Not available

Futuras terapias para el tratamiento de la dislipidemia (Video 9 – Future Therapies for Dyslipidemia Treatment)

See more...

Not available

Uso de inhibidores de PCSK9 en pacientes con hipercolesterolemia familiar (Video 8 – Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patients)

See more...

Not available

Eficacia, viabilidad y seguridad del uso temprano de inhibidores monoclonales de PCSK9 después de un síndrome coronario agudo (Video 7 – Efficacy, Feasibility and Safety of Early Use of Monoclonal PCSK9 Inhibitors After an Acute Coronary Syndrome)

See more...

Not available

Impacto de la inhibición de PCSK9 en pacientes de muy alto riesgo y cómo aumentar la rentabilidad (Video 6 – Impact of PCSK9 Inhibition in Very High-Risk Patients and How to Increase Cost Effectiveness)

See more...

Not available

Impacto del bloqueo de la PCSK9 circulante con anticuerpos monoclonales sobre las lipoproteínas aterogénicas (Video 5 – Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins)

See more...

Not available

Seguridad de la reducción intensiva de LDL-C (Video 4 – Safety of Intensive LDL-C Reduction)

See more...

Not available

Para la prevención de ASCVD, cuanto menor sea el LDL-C, mejor (Video 3 – For ASCVD Prevention the Lower The LDL-C the Better)

See more...

Not available

La triste e inadecuada realidad del control del colesterol en todo el mundo (Video 2 – The Sad and Inadequate Reality of Cholesterol Control Worldwide)

See more...

« » page 1 / 9